Design of a New 99m Tc-radiolabeled Cyclo-peptide as Promising Molecular Imaging Agent of CXCR 4 Receptor: Molecular Docking, Synthesis, Radiolabeling, and Biological Evaluation.
Leila HassanzadehMostafa ErfaniSafura JokarMarjan ShriatpanahiPublished in: Current radiopharmaceuticals (2023)
Therefore, the findings indicate this designed radioligand could be used as a potential SPECT imaging agent in highly proliferated CXCR4 receptor tumors.